IMMUNOGEVITY

Serial Number 98580846
688

Registration Progress

Application Filed
Jun 3, 2024
Under Examination
Mar 25, 2025
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered

Attorney Assistance

Important Deadline Approaching
Notice of Allowance Mailed - SOU Required
Due: September 25, 2025 80 days remaining

Missing this deadline could result in abandonment or cancellation of your trademark.

What would you like to file?

Basic Information

Serial Number
98580846
Deadline
September 25, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
June 3, 2024
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 25, 2025
Application
Pending
Classes
005 042

Rights Holder

Rejuvenation Technologies Inc.

03
Address
415 Clyde Ave. Unit 107
Mountain View, CA 94043

Ownership History

Rejuvenation Technologies Inc.

Original Applicant
03
Mountain View, CA

Rejuvenation Technologies Inc.

Owner at Publication
03
Mountain View, CA

USPTO Deadlines

Next Deadline
80 days remaining
Notice of Allowance Mailed - SOU Required
Due Date
September 25, 2025
Extension Available
Until March 25, 2026

Application History

8 events
Date Code Type Description
Mar 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2024 DOCK D ASSIGNED TO EXAMINER
Dec 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Nutraceuticals for the treatment of or prevention of diseases and conditions of aging; Nutraceuticals for the treatment of or prevention of diseases and conditions of the immune system; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of conditions and diseases of the immune system; Pharmaceutical preparations for the treatment of r prevention of diseases and conditions of aging
Class 042
Research and development in the field of biotechnology; Research and development of medicines

Classification

International Classes
005 042